Clinical Trial Update: A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) [Phase 2]

View source ↗

Summary

Phase 2 open-label study of DISC-3405 in participants with polycythemia vera is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• DISC-3405

Snippet

Sponsor: Disc Medicine, Inc | Conditions: Polycythemia Vera (PV) | Phase 2 | Status: RECRUITING